Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.065 AUD | -9.72% | -28.57% | +195.45% |
04-30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
04-18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+195.45% | 8.53M | |
+29.35% | 684B | |
+29.74% | 568B | |
-4.02% | 361B | |
+18.37% | 329B | |
+4.67% | 284B | |
+16.02% | 240B | |
+9.46% | 208B | |
-6.79% | 200B | |
+8.23% | 166B |
- Stock Market
- Equities
- NYR Stock
- News Nyrada Inc.
- Nyrada Completes Preclinical Dose Formulation for Cholesterol Lowering Medication